Richter Biologics

Richter BioLogics is a world-class and expanding cGMP contract manufacturer (CDMO) of biopharmaceuticals, specialising in products derived from bacteria and yeast, based in Germany. We are recognised as a strong and experienced partner that offers one-stop solutions, including consultancy services. Over the past 35+ years, Richter BioLogics has gained extensive experience in the development and manufacture of various product classes such as proteins, antibodies (VHH, Fab fragments, nanobodies), plasmid DNA (pDNA) using our proprietary pART process and vaccines. The company currently operates one development facility and three cGMP microbial production facilities. Richter BioLogics has now taken the next step in responding to the global demand for CDMO services by adding two more production lines of 300L and 1500L capacity to its Bovenau site. The development facility in Hamburg has also been expanded to provide capacity for new customer projects. Richter BioLogics is committed to meeting its customers' expectations and bringing their products to market in a timely manner. With flexibility, commitment to good manufacturing practice and total transparency, our experienced and motivated teams provide highly specialised contract development and manufacturing services to support the global pharmaceutical and biotechnology industries with process development and supply of products for clinical trials and commercial material. This is continually validated by the major regulatory authorities, including EMA, FDA, ANVISA, PMDA, Health Canada and MFDS, as well as numerous customer audits.